Renee's Bio
Renee Williams advises private and public pharmaceutical, biopharmaceutical, biotechnology, and pharmaceutical services companies on mergers and acquisitions, strategic licensing, and fundraising transactions.
She is an industry executive with a decade of diversified experience working with large global, mid-market, and early-stage life science companies. She has a foundation in the science and business of RNA therapeutics and non-viral delivery for large matrixed companies and entrepreneurial organizations, and direct experience in drug discovery, business operations, and external strategy for a broad range of modalities and therapeutic areas. Navigating complexities and delivering innovative solutions to close deals are hallmarks of her career.
Prior to Woodside Capital Partners, Renee was Vice President of External Strategy for Genetic Medicines at Eli Lilly and Company where she actively shaped the scientific direction by executing 30+ deals in under 24 months for 9 modalities in 6 therapeutic areas within the US, EU, and APAC. This included initiating the ~$500 M acquisition of Akouos auditory gene therapy company, which in January 2024, reported being the first to restore hearing loss in one child who was deaf from birth. Renee started her career at Janssen as an analytical chemist before ultimately being promoted to Global Lead of Business Strategy and Operations for the Infectious Diseases Therapeutic Area.
Native to California, Renee was born in San Francisco and raised in Orange County. She holds a dual MBA from the SC Johnson School of Management at Cornell University and Smith School of Business at Queen’s University (Kingston, Canada). She earned a Doctor of Philosophy (PhD) and Master of Science in chemistry with expertise in mass spectrometry and separation sciences from the University of California, Riverside and California State University, Los Angeles, respectively; and a Bachelor of Science in chemistry with a minor in African-American Studies from University of California, Irvine. Renee also serves as a Director and Advisor on a handful of boards for several start-up companies.
Renee's Media
